Menu

Male LGBQ Students More Likely to Leave STEM Majors Than Their Heterosexual Peers: Study

Women who identified as sexual minorities, however, were more likely to remain in a STEM field.

Mar 16, 2018
Diana Kwon

PIXABAY, NANCYDOWD

Undergraduate students who identify as lesbian, gay, bisexual, or queer (LGBQ) are less likely to remain in science, technology, engineering, and mathematics (STEM) majors than their heterosexual peers, according to a study published this week (March 14) in Science Advances.

Social scientists have suspected this trend, “but it’s nice to see it documented,” Erin Cech, an assistant professor of sociology at the University of Michigan in Ann Arbor who wasn’t involved in the study, tells Nature.

Bruce Hughes, an education researcher at Montana State University and the author of the new study, abandoned engineering after his undergraduate studies. According to Nature, he wondered whether being gay affected that decision, and he set out to investigate whether LGBQ students, in general, were less likely to remain in STEM fields.

After examining data collected from questionnaires completed by more than 4,000 students at 78 US universities during both their freshman and senior years, he found that although more LGBT students reported that they had worked in a lab or had done fieldwork—50 percent versus 41 percent—they were 8 percent less likely to continue majoring in a STEM subject by their senior year.

Interestingly, when Hughes examined women and men separately, he found that while heterosexual men were 17 percent more likely to continue in a STEM field than their LGBT male peers, the opposite was true for women—LGBQ women were 18 percent more likely to remain in STEM than their heterosexual female counterparts.

These findings show that “LGBTQ folks are in science, and we’re interested,” Jeremy Yoder, an assistant professor of biology at California State University in Northridge who wasn’t involved in the work, tells Science. But gay men are “not necessarily finding conditions that make it as easy for us to stay, and that’s worrying.”

A culture change within STEM fields is necessary to make them more inclusive, Hughes tells Inverse. “Obviously, if we retain students who go on to graduate school we will also see more LGBQ faculty,” he says. “But providing a supportive, welcoming environment in which faculty feel they can be open would go a long way toward this goal.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.